Mirum Pharmaceuticals MIRM
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 73.31 | 41.65 | 0.05 | 2,603 | 3 | |
| 2025Q2 | 50.89 | 266.79 | -0.12 | -4,989 | -6 | |
| 2025Q1 | 45.05 | 151.04 | -0.30 | -15,183 | -15 | |
| 2024Q4 | 41.35 | 116.52 | -0.49 | -24,222 | -24 | |
| 2024Q3 | 39.00 | 123.12 | -0.30 | -12,684 | -14 | |
| 2024Q2 | 34.19 | 118.59 | -0.52 | -24,232 | -25 | |
| 2024Q1 | 25.12 | 125.57 | -0.54 | -26,468 | -25 | |
| 2023Q4 | 29.52 | 102.24 | -0.72 | -32,585 | -36 | |
| 2023Q3 | 31.60 | 127.24 | -0.53 | -25,148 | -24 | |
| 2023Q2 | 25.87 | 34.68 | -1.95 | -24,273 | -74 | |
| 2023Q1 | 24.02 | 105.69 | -0.80 | -27,148 | -30 | |
| 2022Q4 | 19.50 | 106.98 | -0.99 | -34,161 | -36 | |
| 2022Q3 | 21.01 | 103.66 | -1.03 | -32,882 | -36 | |
| 2022Q2 | 19.46 | 106.16 | -0.83 | -31,441 | -27 | |
| 2022Q1 | 22.02 | 99.74 | -1.17 | -32,736 | -37 | |
| 2021Q4 | 15.95 | -74.32 | 1.91 | -45,575 | 58 | |
| 2021Q3 | 19.92 | 103.36 | -1.55 | -42,824 | -47 | |
| 2021Q2 | 17.29 | 95.64 | -1.45 | -37,401 | -44 | |
| 2021Q1 | 19.82 | 100.99 | -1.68 | -47,613 | -51 | |
| 2020Q4 | 17.46 | 100.23 | -1.44 | -36,951 | -37 |